Quick Answer
KESTRA MEDICAL TECHNOLOGIES, LTD. reported Research And Development Expense of $15.65 million for the year ending 2025.
- KESTRA MEDICAL TECHNOLOGIES, LTD. showed an increase of +1.0% in Research And Development Expense from 2024 to 2025.
- This data is from KESTRA MEDICAL TECHNOLOGIES, LTD.'s annual report (Form 10-K), filed with the SEC on July 17, 2025.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $15.65 million | Fiscal year 2024: $15.49 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: